Trending
News
Dr. Daniel Sieiro Mosti Joins Plexus Ventures as Scientific Associate for Gene and Cell Therapies
Philadelphia, Pennsylvania – Plexus Ventures announces the appointment of Dr. Daniel Sieiro Mosti as Scientific Associate. Dr. Sieiro is a former research fellow at Harvard Medical School where he focused on the genetic basis of tissue development in health and...
Plexus Ventures advises Cinfa Group in PLG’s “Deal of the Year”
London, England – The Pharmaceutical Licensing Group, whose mission is promote and support excellence in deal making across the healthcare industry, recently awarded Mundipharma International its inaugural “PLG Deal of the Year” for its acquisition of Cinfa Biotech....
Plexus Ventures Appoints Pierfrancesco Maschio as Director for Southern Europe
Philadelphia, Pennsylvania – Plexus Ventures announces the appointment of Pierfrancesco Maschio, based in Milan, as Director for Southern Europe. Pierfrancesco is a long-time entrepreneur who has successfully built his Ricerchimica healthcare business development...
Plexus Ventures Assists Laboratorios Cinfa in Selling Biosimilar Business to Mundipharma
Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful conclusion of a divestiture project for its client, Laboratorios Cinfa, S.A. of Pamplona, Spain. Plexus Ventures advised Cinfa on the sale of its biosimilar business, Cinfa Biotech to a...
Mabion S.A. completes marketing authorization application for flagship drug, MabionCD20, to the European Medicines Agency (EMA)
Plexus Ventures would like to share successful news from Mabion S.A. Additional details are provided in Mabion’s press release (Konstantynów Łódzki, 1.06.2018): • Company submitted the marketing authorization application under the centralized authorization procedure...
Plexus Ventures Assists Fujifilm Kyowa Kirin Biologics in Partnering with Mylan of Humira® Biosimilar
Tokyo, Japan – Plexus Ventures is pleased to announce the successful conclusion of an out-licensing project of its client Fujifilm Kyowa Kirin Biologics Co., Ltd. Plexus Ventures provided professional services to Fujifilm Kyowa Kirin Biologics to partner the European...
Plexus Ventures Assists Glenmark Pharmaceuticals to Out-License Ryaltris™ Nasal Spray to Menarini for numerous markets throughout Europe
Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful conclusion of a licensing agreement of behalf of our client, Glenmark Pharmaceuticals. Mr. Michael O’Sullivan, Plexus Ventures’ Managing Partner, stated: “This transaction is an ideal...
Plexus Ventures Appoints Ramon Brusco as Director for Spain, Portugal and MENA
Philadelphia, Pennsylvania – Plexus Ventures announces the appointment of Ramon Brusco, based in Barcelona, as Director for Spain and Portugal. Ramon has more than 20 years’ experience with pharmaceutical firms and M&A boutiques focused on Life Sciences. He brings...
How can we help you?
Plexus Ventures assists with M&A, divestments, licensing, strategic advice and consulting.
Subscribe to
Plexus News
Follow Us
Check out Plexus Ventures and other industry news shared daily.